DI PUNZIO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 318
EU - Europa 277
AS - Asia 61
AF - Africa 1
OC - Oceania 1
Totale 658
Nazione #
US - Stati Uniti d'America 317
IT - Italia 82
IE - Irlanda 79
SE - Svezia 64
CN - Cina 53
GB - Regno Unito 14
DE - Germania 13
BE - Belgio 11
FR - Francia 8
FI - Finlandia 4
IN - India 3
RU - Federazione Russa 2
AU - Australia 1
AZ - Azerbaigian 1
CA - Canada 1
IR - Iran 1
JP - Giappone 1
SG - Singapore 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 658
Città #
Chandler 84
Dublin 68
Ann Arbor 64
Ashburn 19
Shanghai 17
Beijing 13
Princeton 12
Brussels 11
Dearborn 11
Colchester 8
Los Angeles 8
Parma 8
Gravina di Catania 7
Wilmington 7
Fontanellato 6
New York 6
Woodbridge 6
Des Moines 5
Avola 4
Bologna 4
Falls Church 4
Ferrara 4
Helsinki 4
Messina 4
Nanjing 4
Piacenza 4
Reggio Nell'emilia 4
Rome 4
Scafati 4
Trezzano Sul Naviglio 4
Boardman 3
Bremen 3
Brescia 3
Houston 3
Jinan 3
Pune 3
Zhengzhou 3
Carpi 2
Dosolo 2
Fremont 2
Guangzhou 2
Kunming 2
Milan 2
Nanchang 2
Pistoia 2
Redmond 2
Saint-Fons 2
Slough 2
St Petersburg 2
Taiyuan 2
Baku 1
Berlin 1
Cambridge 1
Cape Town 1
Elyria 1
Fuzhou 1
Garching 1
Gloucester 1
Hangzhou 1
Istanbul 1
La Jolla 1
Langhirano 1
Leawood 1
Lecce 1
Manchester 1
Marseille 1
Melbourne 1
Modena 1
Ningbo 1
Novara 1
Padova 1
Peterborough 1
Philadelphia 1
Rockville 1
Sabz 1
San Gregorio di Catania 1
Seattle 1
Stockholm 1
Tappahannock 1
Tokyo 1
Toronto 1
Vezzano sul Crostolo 1
Washington 1
Xian 1
Totale 489
Nome #
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 75
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 68
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 67
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 63
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 62
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 60
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 54
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 52
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 46
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 45
The power of yeast in modeling human mutations leading to mitochondrial disease 42
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 39
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 11
Totale 684
Categoria #
all - tutte 2.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 9 11 9 2 2 8 11 3 3 6 6 2
2020/202183 2 1 16 2 5 4 4 3 9 22 7 8
2021/2022110 9 3 0 16 6 20 4 8 2 4 5 33
2022/2023303 30 34 34 19 18 31 9 15 89 2 15 7
2023/2024116 15 13 6 12 9 20 10 9 4 12 6 0
Totale 684